Lee Hebert
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Renin-Angiotensin System Studies
Papers in
-
- Renal Diseases and Glomerulopathies 6
- Chronic Kidney Disease and Diabetes 2
-
- Systemic Lupus Erythematosus Research 5
- Co-authors
- DeJuran Richardson (1 shared paper)İmke Janssen (1 shared paper)Rajiv Agarwal (1 shared paper)W. Kline Bolton (1 shared paper)George L. Bakris (1 shared paper)Daniel F. Catanzaro (1 shared paper)Brad H. Rovin (3 shared papers)Tibor Nádasdy (2 shared papers)
- Journals
- Clinical Nephrology (4 papers)Kidney International (4 papers)American Journal of Kidney Diseases (2 papers)American Journal of Hypertension (1 paper)Kidney International Reports (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Lee Hebert
12 papers receiving 380 citations
Peers
Comparison fields: 5 of 58
- Nephrology 149
- Cardiology and Cardiovascular Medicine 166
- Pulmonary and Respiratory Medicine 162
- Rheumatology 74
- Endocrinology, Diabetes and Metabolism 69
Countries citing papers authored by Lee Hebert
This map shows the geographic impact of Lee Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Hebert more than expected).
Fields of papers citing papers by Lee Hebert
This network shows the impact of papers produced by Lee Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Hebert. The network helps show where Lee Hebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Hebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 185 | |
| 2 | 2004 | 54 | |
| 3 | 1996 | 44 | |
| 4 | 1994 | 39 | |
| 5 | 2014 | 24 | |
| 6 | Angiotensin converting enzyme inhibition in diabetic nephropathy | 1994 | 13 |
| 7 | 2018 | 11 | |
| 8 | 2018 | 8 | |
| 9 | 2017 | 6 | |
| 10 | 2021 | 6 | |
| 11 | 1986 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 0 |
About Lee Hebert
Lee Hebert is a scholar working on Nephrology, Rheumatology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics, having authored 13 papers that have together received 402 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Systemic Lupus Erythematosus Research (5 papers), Blood Pressure and Hypertension Studies (2 papers), Complement system in diseases (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Cardiac Arrhythmias and Treatments (1 paper), Drug-Induced Ocular Toxicity (1 paper) and Electrolyte and hormonal disorders (1 paper). The work is most often cited by research in Nephrology (149 citations), Cardiology and Cardiovascular Medicine (166 citations), Pulmonary and Respiratory Medicine (162 citations), Rheumatology (74 citations) and Endocrinology, Diabetes and Metabolism (69 citations). Lee Hebert has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include DeJuran Richardson, İmke Janssen, Rajiv Agarwal, W. Kline Bolton, George L. Bakris, Daniel F. Catanzaro, Brad H. Rovin, Tibor Nádasdy, Todd E. Pesavento and Yuxiao Tang. Their work appears in journals such as Clinical Nephrology, Kidney International, American Journal of Kidney Diseases, American Journal of Hypertension and Kidney International Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.